Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Once-Weekly vs. Thrice-Weekly Recombinant Factor VIII in Severe Hemophilia A
NCT01405742Phase 3Terminated
- Sponsor
- University of Pittsburgh
- Start
- Jul 2012
- Primary completion
- Nov 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant human coagulation factor VIII in hemophilia A, sponsored by University of Pittsburgh. Started Jul 2012; status: terminated.
02
Drugs
recombinant human coagulation factor VIII
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT01405742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01405742.